Active Trials
Pulmonary Hypertension
Protocol No. AMB-323: ARIES-3: A Phase 3, Long-term, Open-label, Multicenter Safety and Efficacy Study of Ambrisentan in Subjects with Pulmonary Hypertension
Protocol No. AC-052-414: Effects of Combination of Bosentan and Sildenafil versus Sildenafil Monotherapy on Morbidity and Mortality in Symptomatic Patients with Pulmonary Arterial Hypertension - A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Prospective, Event Driven Phase IV study
Pulmonary Hypertension Quality Enhancement Research Initiative (QuERI)
Scleroderma Pulmonary Hypertension Quality Enhancement Research Initiative (QuERI)
Chronic Obstructive Pulmonary Disease (COPD)
Protocol No. 1012.56: A comparison of ipratropium bromide/salbutamol delivered by the Respimat® inhaler to COMBIVENT® Inhalation Aerosol and ipratropium bromide delivered by the Respimat® in a 12-week, doubleblind, safety and efficacy study in adults with chronic obstructive pulmonary disease
Insomnia
Protocol No. Organon 176002: A Six-Week, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Efficacy and Safety, Sleep Lab Trial with Org 50081 in Patients with Chronic Primary Insomnia.
Atrial Fibrillation
Protocol No. OM8 AFib: A Randomized, Double-Blind, Placebo Controlled, Parallel-Group Trial to Assess The Efficacy and Safety of Omacor® For The Prevention of Recurrent, Symptomatic Atrial Fibrillation
Upcoming Trials
coming soon...
